CD34+/CD33+ Blast Cells: Correlation with FAB Subtypes

References

• Castoldi G. L., Liso V., Fenu S., Vegna L., Mandelli F. Reproducibility of the morphological diagnostic criteria for acute myeloid leukemia: the GIMEMA group experience. Ann. Hematol. 1993; 66: 171–174
   PubMed Web of Science ®Google Scholar
• Terstappen L. W. M. M., Safford M., Konemann S., Loken M. R., Zurlutter K., Buchner T., Hiddemann W., Wörmann B. Flow cytometric characterisation of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 1991; 5: 757–767
   Web of Science ®Google Scholar
• Bennett J. M., Catowsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Intern. Med. 1985; 103: 626–629
   PubMed Web of Science ®Google Scholar
• Castoldi G. L., Cuneo A., Lanza F., Tomasi P. Diagnosis of leukemia: morphology. Leukemia 1992; 6: 6–9, Suppl. 4
   PubMed Web of Science ®Google Scholar
• Shaw S., . Antibodies and molecules of the 5th International Workshop of Leukocyte Differentiation Antigens, in, Leukocyte Typing V: White Cell Differentiation Antigens, S. Schlossman, L. Boumsell, W. Gilks, J. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. Tedder, R. Todd, et al. Oxford University Press. 1994, in press
   Google Scholar
• Kaplan E. L., Meier P. Non-parametric estimation from incomplete observations. J. Amer. Stat. Assoc. 1958; 53: 457–481
   Web of Science ®Google Scholar
• Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPerson K., Peot J., Smith P. J. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Brit. J. Cancer. 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Devaux Y., Treille D., Larese A., Maupas J., Gentilhomme O., Ehrsam A., Fiere D. Surface marker expression in adult acute myeloid leukemia: correlations with initial characteristics. morphology and response to therapy. Brit. J. Haematol. 1989; 72: 161–166
   PubMed Web of Science ®Google Scholar
• Solary E., Casanovas O., Campos L., Béné M. C., Faure G., Maingon P., Falkenrodt A., Lenhormand B., Genetet Geil N. Surface markers in adult myeloblastic leukemia: correlation of CD 19+, CD34+ and CD14+/DR- phenotypes with shorter survival. Leukemia 1992; 6: 393–399
   PubMed Web of Science ®Google Scholar
• Geller R., Zahurak M., Hurwitz A., Burke P. J., Karp J. E., Piantadosi S., Civin C. I. Prognostic importance of immunophenotyping in adults with acute myelocytic leukemia: the significance of the stem-cell glyco-protein CD34 (My 10). Brit. J. Haematol. 1990; 76: 340–347
   PubMed Web of Science ®Google Scholar
• Sperling C., Buchner T., Sauerland C., Fonatsch C., Thel E., Ludwig W. CD34 expression in de novo acute myeloid leukemia. Brit. J. Haematol. 1993; 84: 635–637
   Google Scholar
• Terstappen L. W. M. M., Konemann S., Safford M., Loken M. R., Zurlutter K., Buchner T., Hiddemann W., Wormann B. Flow cytometric characterisation of acute myeloid leukemia. Part I. significance of light scattering properties. Leukemia 1991; 5: 315–321
   PubMed Web of Science ®Google Scholar
• Verwer B. J. H., Terstappen L. W. M. M. Automatic lineage assignment of acute leukemias by flow cytometry. Cytometry 1993; 14: 862–875
   PubMedGoogle Scholar
• Kawada H., Ichikawa Y., Watanabe S., Nagao T., Arimori S. Flow cytometry analysis of cell-surface antigen expressions on acute myeloid leukemia cell populations according to their cell-size. Leukemia Res. 1994; 18: 29–35
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Guenther K. L., Shults K. E., Stelzer G. T. Immunophenotyping of acute leukemia by flow cytometric analysis. Am. J. Clin. Pathol. 1993; 100: 534–540
   PubMed Web of Science ®Google Scholar
• Pirelli L., Teofili L., Menichella G., Rumi C., Paoloni A., Iovino S., Puggioni P. L., Leoni G., Bizzi B. Further investigations on the expression of HLA-DR, CD33 and CD 13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells. Brit. J. Haematol. 1993; 84: 24–30
   PubMed Web of Science ®Google Scholar
• Pontvert-Delucq S., Breton-Gorius J., Schmitt C., Baillou C., Guichard J., Najman A., Lemoine M. Characterisation and functional analysis of adult human bone-marrow cell subsets in relation to B-lymphoid development. Blood 1993; 82: 417–429
   PubMed Web of Science ®Google Scholar
• Terstappen L. W. M. M., Safford M., Unterhalt M., Könemann S., Zurlutter K., Piechotka K., Drescher M., Aul C., Buchner T., Hiddemann W., Wörmann B. Flow cytometric characterisation of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal haematopoietic progenitors cells. Leukemia 1992; 6: 993–1000
   PubMed Web of Science ®Google Scholar
• Terstappen L. W. M. M., Huang S., Safford M., Lansdorp M., Loken M. R. Sequential generation of hematopoietic colonies derived from single nonlineage-committed CD34+ CD38-progenitors cells. Blood 1991; 77: 1218–1227
   PubMed Web of Science ®Google Scholar
• Lanza F., Rigolin G. M., Moretti S., Latorraca A., Castoldi G. L. Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia. Leuk. Lymph. 1994; 13: 81–85, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Kita K., Nakase K., Miwa H., Masuya M., Nishil K., Morita N., Takakura N., Otsuji A., Shirakawa S., Ueda T., Nasu K., Kyo T., Dohy H., Kamada N. Phenotypical characterisation of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD 19 together with stem cell CD34. Blood 1992; 80: 470–477
   PubMed Web of Science ®Google Scholar
• Fagioli F., Cuneo A., Carli M. G., Bardi A., Piva N., Previati R., Rigolin G. M., Ferrari L., Spanedda R., Castoldi G. L. Chromosome aberrations in CD34–positive acute myeloid leukemia. Correlation with clinicopathologic features. Cancer Genet. Cytogenet. 1993; 71: 119–124
   PubMed Web of Science ®Google Scholar
• Seshi B., Kashyap A., Bennett J. M. Acute myeloid leukemia with unusual phenotype: myeloperoxidase (+), CD13(-). CD14(-) and CD33(-). Brit. J. Haematol. 1992; 81: 374–377
   PubMed Web of Science ®Google Scholar
• De Boekhorst P. A. W., De Leeuw K., Wittebool G., Nooter K., Hagemrijer A., Löwrnbergh B., Sonneveld P. Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood 1993; 82: 3157–3162
   PubMed Web of Science ®Google Scholar